GLG Partners’s AVEO Pharmaceuticals AVEO Stock Holding History
Bought
Maintained
Sold
Other funds holding AVEO
6CM
GLG Partners's AVEO Position: Q4 2017 in Review
GLG Partners opened a new position in AVEO Pharmaceuticals (AVEO) in Q4 2017: 2,520 shares worth $70K. The stake represents ﹤0.01% of the portfolio and ranks #434 among its holdings.
84 funds tracked by Wall St. Rank hold AVEO as of Q4 2017.
- GLG Partners held 2,520 shares of AVEO Pharmaceuticals worth $70K as of Q4 2017.
- AVEO Pharmaceuticals was a new GLG Partners position in Q4 2017.
- AVEO Pharmaceuticals made up ﹤0.01% of GLG Partners's portfolio in Q4 2017, its #434 holding.
- 84 funds tracked by Wall St. Rank held AVEO Pharmaceuticals as of Q4 2017.
Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.